| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 140, 639-648, Copyright © 1992 by American Society for Investigative Pathology
REGULAR ARTICLES |
A Smits, K Funa, FS Vassbotn, M Beausang-Linder, F af Ekenstam, CH Heldin, B Westermark and M Nister
Ludwig Institute for Cancer Research, Biomedical Center, Uppsala, Sweden.
Platelet-derived growth factor (PDGF) is known to stimulate the proliferation of connective tissue-derived cells in vitro. Less is known about its functions in vivo, and the role of PDGF in the development of human tumors has not been clarified. The authors have investigated the occurrence of PDGF and PDGF receptors in a series of proliferative disorders of fibroblastic origin using immunohistochemical and in situ hybridization techniques. High expression of PDGF beta-receptor mRNA and protein was found in the malignant tumors, and also in some benign lesions, such as dermatofibroma. In all these cases, benign as well as malignant, the PDGF B-chain mRNA, and less clearly, the PDGF A-chain mRNA, were coexpressed with the beta-receptor. In contrast, high expression of PDGF alpha-receptor mRNA was only found in fully malignant lesions, i.e., malignant fibrous histiocytoma. These data indicate that an autocrine growth stimulation via the PDGF beta-receptor could occur in an early phase of tumorigenesis, and may be a necessary but insufficient event for the progression into fully malignant human connective tissue lesions.
This article has been cited by other articles:
![]() |
W. Lederle, H.-J. Stark, M. Skobe, N. E. Fusenig, and M. M. Mueller Platelet-Derived Growth Factor-BB Controls Epithelial Tumor Phenotype by Differential Growth Factor Regulation in Stromal Cells Am. J. Pathol., November 1, 2006; 169(5): 1767 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sjoblom, A. Shimizu, K. P. O'Brien, K. Pietras, P. Dal Cin, E. Buchdunger, J. P. Dumanski, A. Ostman, and C.-H. Heldin Growth Inhibition of Dermatofibrosarcoma Protuberans Tumors by the Platelet-derived Growth Factor Receptor Antagonist STI571 through Induction of Apoptosis Cancer Res., August 1, 2001; 61(15): 5778 - 5783. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Heldin and B. Westermark Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor Physiol Rev, October 1, 1999; 79(4): 1283 - 1316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shimizu, K. P. O'Brien, T. Sjoblom, K. Pietras, E. Buchdunger, V. P. Collins, C.-H. Heldin, J. P. Dumanski, and A. Ostman The Dermatofibrosarcoma Protuberans-associated Collagen Type I{{alpha}}1/Platelet-derived Growth Factor (PDGF) B-Chain Fusion Gene Generates a Transforming Protein That Is Processed to Functional PDGF-BB Cancer Res., August 1, 1999; 59(15): 3719 - 3723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Crosby, K. A. Tappan, R. A. Seifert, and D. F. Bowen-Pope Chimera Analysis Reveals That Fibroblasts and Endothelial Cells Require Platelet-Derived Growth Factor Receptorß Expression for Participation in Reactive Connective Tissue Formation in Adults but Not during Development Am. J. Pathol., May 1, 1999; 154(5): 1315 - 1321. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takata, Y. Kitami, T. Fukuoka, T. Okura, and K. Hiwada Novel Cis Element for Tissue-Specific Transcription of Rat Platelet-Derived Growth Factor ß-Receptor Gene Hypertension, January 1, 1999; 33(1): 298 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Waltenberger, M. L. Akyurek, M. Aurivillius, A. Wanders, E. Larsson, B. Fellstrom, and K. Funa Ischemia-Induced Transplant Arteriosclerosis in the Rat: Induction of Peptide Growth Factor Expression Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1516 - 1523. [Abstract] [Full Text] |
||||
![]() |
S. Valgeirsdóttir, A. Eriksson, M. Nistér, C.-H. Heldin, B. Westermark, and L. Claesson-Welsh Compartmentalization of Autocrine Signal Transduction Pathways in Sis-transformed NIH 3T3 Cells J. Biol. Chem., April 28, 1995; 270(17): 10161 - 10170. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |